Evidence map›Paper›PMID 19527557›Full record

ReviewCanadian journal of psychiatry. Revue canadienne de psychiatrie2009

Treatment of tobacco dependence in mental health and addictive disorders.

Brian Hitsman, Taryn G Moss, Ivan D Montoya, Tony P George

Registry-linked trialOpen access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02378714 (Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers), which is not on this map. Cited by 49 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 4 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02378714 phase4completednot on this mapstarted 2015, after this paper: background citation

Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers

TypeinterventionalSponsorNorthwestern UniversityRan2015 to 2020Enrolled300ConditionsNicotine Dependence, Major Depressive DisorderArmsVarenicline, BASC, Standard treatment
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 4 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Smoking cessation interventions for smokers with current or past depression.The Cochrane database of systematic reviews · 2013
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Brian HitsmanDepartment of Preventive Medicine, Northwestern University, Chicago, Illinois 60611, USA. b-hitsman@northwestern.edu
Taryn G Moss
Ivan D Montoya
Tony P George
Centre for Addiction and Mental Health · CANational Institute on Drug Abuse · USNorthwestern University · USUniversity of Toronto · CA

Funding

Selegiline for Smoking CessationR01DA015757 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2004 to 2007
$1.4M
Optimizing Treatment for Schizophrenic SmokersR01DA013672 · NIDA · YALE UNIVERSITY · PI GEORGE, TONY P · 2001 to 2004
$848k
Nicotinic Receptors and Cog Function in SchizophreniaR01DA014039 · NIDA · YALE UNIVERSITY · PI GEORGE, TONY P · 2001 to 2003
$627k
Neurobehavioral Regulation of Cigarette CravingsK08DA017145 · NIDA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HITSMAN, BRIAN L · 2004 to 2008
$626k
Translational Studies on Smoking in SchizophreniaK02DA016611 · NIDA · YALE UNIVERSITY · PI GEORGE, TONY P · 2004 to 2006
$307k
Intramural NIH HHS Z99 DA999999NIDA NIH HHS K02 DA016611NIDA NIH HHS K02 DA16611NIDA NIH HHS K08 DA017145NIDA NIH HHS R01 DA013672NIDA NIH HHS R01 DA014039NIDA NIH HHS R01 DA015757NIDA NIH HHS R01 DA13672NIDA NIH HHS R01 DA14039NIDA NIH HHS R01 DA15757
6 · The paper itself

Abstract

People with mental health and addictive (MHA) disorders smoke at high rates and require tobacco treatment as a part of their comprehensive psychiatric care. Psychiatric care providers often do not address tobacco use among people with mental illness, possibly owing to the belief that their patients will not be able to quit successfully or that even short-term abstinence will adversely influence psychiatric status. Progress in the development of treatments has been slow in part because smokers with current MHA disorders have been excluded from most smoking cessation trials. There are several smoking cessation treatment options, including psychological and pharmacological interventions, that should be offered to people with an MHA disorder who smoke. Building motivation and readiness to quit smoking is a major challenge, and therefore motivational interventions are essential. We review the treatment options for people with tobacco dependence and MHA disorders, offer recommendations on tobacco assessment and tailored treatment strategies, and provide suggestions for future research. Treatment efficacy could be enhanced through promoting smoking reduction as an initial treatment goal, extending duration of treatment, and delivering it within an integrated care model that also aims to reduce the availability of tobacco in MHA treatment settings and in the community.

Indexed as

Smoking CessationCombined Modality TherapyComorbidityDelivery of Health Care, IntegratedGoalsHumansMental DisordersSecondary PreventionSmokingSubstance-Related DisordersTobacco Use Disorder

Identifiers

PMID19527557
PMCPMC3632078
OpenAlexW1490356790

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.